Literature DB >> 26183924

Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.

Monica Bodogai1, Kanako Moritoh1, Catalina Lee-Chang1, Christine M Hollander2, Cheryl A Sherman-Baust1, Robert P Wersto3, Yoshihiko Araki4, Ichiro Miyoshi5, Li Yang2, Giorgio Trinchieri6, Arya Biragyn7.   

Abstract

Myeloid-derived suppressive cells (MDSC) have been reported to promote metastasis, but the loss of cancer-induced B cells/B regulatory cells (tBreg) can block metastasis despite MDSC expansion in cancer. Here, using multiple murine tumor models and human MDSC, we show that MDSC populations that expand in cancer have only partially primed regulatory function and limited prometastatic activity unless they are fully educated by tBregs. Cancer-induced tBregs directly activate the regulatory function of both the monocyte and granulocyte subpopulations of MDSC, relying, in part, on TgfβR1/TgfβR2 signaling. MDSC fully educated in this manner exhibit an increased production of reactive oxygen species and NO and more efficiently suppress CD4(+) and CD8(+) T cells, thereby promoting tumor growth and metastasis. Thus, loss of tBregs or TgfβR deficiency in MDSC is sufficient to disable their suppressive function and to block metastasis. Overall, our data indicate that cancer-induced B cells/B regulatory cells are important regulators of the immunosuppressive and prometastatic functions of MDSC. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26183924      PMCID: PMC4558269          DOI: 10.1158/0008-5472.CAN-14-3077

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

Review 1.  B-cell targeted therapies in human autoimmune diseases: an updated perspective.

Authors:  Michael J Townsend; John G Monroe; Andrew C Chan
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

2.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

Review 3.  Review of the activation of TGF-beta in immunity.

Authors:  Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

4.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Authors:  Purevdorj B Olkhanud; Bazarragchaa Damdinsuren; Monica Bodogai; Ronald E Gress; Ranjan Sen; Katarzyna Wejksza; Enkhzol Malchinkhuu; Robert P Wersto; Arya Biragyn
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

5.  B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.

Authors:  Massimo Ammirante; Jun-Li Luo; Sergei Grivennikov; Sergei Nedospasov; Michael Karin
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

6.  Macrophage polarization to a unique phenotype driven by B cells.

Authors:  Siew-Cheng Wong; Anne-Laure Puaux; Manesh Chittezhath; Irina Shalova; Tasneem S Kajiji; Xiaojie Wang; Jean-Pierre Abastado; Kong-Peng Lam; Subhra K Biswas
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

7.  Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.

Authors:  Chien-Ying Liu; Yu-Min Wang; Chih-Liang Wang; Po-Hao Feng; How-Wen Ko; Yun-Hen Liu; Yi-Cheng Wu; Yen Chu; Fu-Tsai Chung; Chih-Hsi Kuo; Kang-Yun Lee; Shu-Min Lin; Horng-Chyuan Lin; Chun-Hua Wang; Chih-Teng Yu; Han-Pin Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

8.  IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

Authors:  Susanna Mandruzzato; Samantha Solito; Erika Falisi; Samuela Francescato; Vanna Chiarion-Sileni; Simone Mocellin; Antonio Zanon; Carlo R Rossi; Donato Nitti; Vincenzo Bronte; Paola Zanovello
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

Review 9.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

10.  TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells.

Authors:  Charalambos Michaeloudes; Maria B Sukkar; Nadia M Khorasani; Pankaj K Bhavsar; Kian Fan Chung
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

View more
  65 in total

Review 1.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

Review 2.  Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer.

Authors:  Asha Jayakumar; Alfred L M Bothwell
Journal:  J Immunol       Date:  2019-09-01       Impact factor: 5.422

Review 3.  Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.

Authors:  Si-Si Wang; Wei Liu; Dalam Ly; Hao Xu; Limei Qu; Li Zhang
Journal:  Cell Mol Immunol       Date:  2018-04-08       Impact factor: 11.530

4.  Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.

Authors:  Chih-Hang Tang; Shiun Chang; Ayumi Hashimoto; Yi-Ju Chen; Chang Won Kang; Anthony R Mato; Juan R Del Valle; Dmitry I Gabrilovich; Chih-Chi Hu
Journal:  Cancer Immunol Res       Date:  2018-04-12       Impact factor: 11.151

5.  Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.

Authors:  Amy W Ku; Jason B Muhitch; Colin A Powers; Michael Diehl; Minhyung Kim; Daniel T Fisher; Anand P Sharda; Virginia K Clements; Kieran O'Loughlin; Hans Minderman; Michelle N Messmer; Jing Ma; Joseph J Skitzki; Douglas A Steeber; Bruce Walcheck; Suzanne Ostrand-Rosenberg; Scott I Abrams; Sharon S Evans
Journal:  Elife       Date:  2016-12-08       Impact factor: 8.140

6.  TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.

Authors:  Kavitha Premkumar; Bhavani S Shankar
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

Review 7.  Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  Peng Qu; Li-Zhen Wang; P Charles Lin
Journal:  Cancer Lett       Date:  2015-10-28       Impact factor: 8.679

Review 8.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

Review 9.  Cancer vaccines: translation from mice to human clinical trials.

Authors:  Hoyoung Maeng; Masaki Terabe; Jay A Berzofsky
Journal:  Curr Opin Immunol       Date:  2018-03-16       Impact factor: 7.486

10.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.